ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1857

If Mobile Advertising Is the Future, the Future Is Now:  Productivity of Digital Ads By Terminology and Delivery Device.

Teresa J. Brady1 and Kamil E. Barbour2, 1Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, 2Centers for Disease Control and Prevention, Atlanta, GA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Chronic disease care, communication and self-management, Marketing

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: ARHP Education/Community Programs

Session Type: ARHP Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

CDC is pilot-testing a multi-modal marketing campaign to promote self-management education (SME) as a chronic disease management strategy. The campaign targets adults ages 45-75 with any chronic condition, including arthritis. The campaign includes both earned and paid media (i.e., radio, out-of-home, print, and digital advertising) with a call-to-action to visit www.cdc.gov/LearnMoreFeelBetter to learn more about SME.

Formative audience research indicated that consumers preferred “ongoing” over “chronic” to describe their health condition, but paradoxically, they used “chronic” when describing their condition.

One element of the paid media campaign strategy is the presentation of digital ads (similar to pop-up ads) to desktop computers, tablets, and smart phones to consumers likely to have chronic conditions. Digital ads were used in the first 9 weeks of the campaign pilot-test (January 23-March 26, 2017).

The purposes of this observational study are to determine whether: 1) “ongoing” or “chronic” terminology in ads is more productive, and 2) ads presented via desktop computer or mobile device (tablet, smartphone) are more productive.

Methods:

Two versions of the digital ads were produced; ads were identical except for the use of “ongoing” or “chronic.”

A commercial vendor distributed the digital ads to consumers likely to have a chronic disease using a proprietary algorithm that used demographic and consumer spending data to identify consumers likely to have chronic conditions.

Ad productivity was defined as visits to the campaign home page and data was collected using Site Catalyst, a web analytics software program.

Productivity was measured in 3 ways:

  1. Click thru Rate: Percentage of people who clicked on the ad out of all exposed to ad;

  2. Cost per Click: Total costs to run ad to the device divided by number of clicks;

  3. Minutes on Site: Average number of minutes spent on the site by those who clicked through from ad to campaign website.

Results:

A total of 8,887 visits (from all sources) were made to the campaign home page during the first flight of digital ads. The following table reports productivity of digital ads by Click-Thru Rate, Cost per Click and Minutes on Site for ads using “ongoing” or “chronic” terminology.

Click-Thru Rate (CTR)

Cost per Click (CPC)

Minutes on Site (MoS)

Mobile

Desktop

Mobile

Desktop

Mobile

Desktop

“Chronic”

0.36%

0.13%

$0.87

$3.08

6.36

2.12

“Ongoing”

0.34%

0.13%

$0.90

$3.04

6.06

2.03


Conclusion:

Results were consistent across all 3 measures of productivity. Although audience research suggested that consumers prefer “ongoing” to “chronic“ in describing their health condition, ads using either term were similarly productive in prompting consumers to visit the campaign home page. Ads can use either “ongoing” or “chronic” to describe long-term health conditions with equal effectiveness.

However, ads appearing on mobile devices were nearly 3 times as productive as ads appearing on desktop computers across all 3 measures. If dollars are limited, placing digital ads on mobile devices, rather than desktop computers, will be a better investment.


Disclosure: T. J. Brady, None; K. E. Barbour, None.

To cite this abstract in AMA style:

Brady TJ, Barbour KE. If Mobile Advertising Is the Future, the Future Is Now:  Productivity of Digital Ads By Terminology and Delivery Device. [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/if-mobile-advertising-is-the-future-the-future-is-now-productivity-of-digital-ads-by-terminology-and-delivery-device/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/if-mobile-advertising-is-the-future-the-future-is-now-productivity-of-digital-ads-by-terminology-and-delivery-device/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology